Years of fertility treatment can pass without a clear explanation. Repeated miscarriages, failed embryo transfers, and cycles that end the same way each time leave many patients holding a folder of normal results and no answer to the question of what went wrong.
Standard fertility care investigates the biology of conception, and it does that well. Reproductive immunology examines something different, which is how the immune system responds once conception has happened. For patients whose conventional testing came back clear, that difference is often where the remaining answers sit.
What Does A Standard Fertility Clinic Evaluate?
Conventional fertility care investigates the physical and hormonal requirements for conception. The evaluation is thorough within its scope and identifies the cause for most patients who seek treatment.
A standard workup typically covers:
- Ovarian function: ovarian reserve testing, follicle counts, and response to stimulation
- Embryo quality: fertilization rates, blastocyst development, and genetic screening
- Uterine anatomy: imaging and hysteroscopy to identify fibroids, polyps, or adhesions
- Hormonal profile: thyroid function, prolactin, and progesterone support
- Male factor: semen analysis and related evaluation
- Genetic factors: karyotype testing for both partners
When this evaluation identifies a cause, treatment follows a well-established path. Patients who reach a reproductive immunology practice are usually those whose results returned normal across every category.
What Does Reproductive Immunology Look At Instead?
Reproductive immunology begins where conventional testing ends. Rather than asking whether conception is biologically possible, it examines whether the immune system will support a pregnancy once implantation begins.
The Immune Challenge of Pregnancy
An embryo carries genetic material from both parents, which makes it partly foreign to the mother’s body. A healthy pregnancy depends on the immune system recognizing that difference and responding with tolerance rather than rejection.
Uterine immune cells sit at the center of this process. They remodel the blood vessels supplying the developing placenta, guide the embryo into the uterine lining, and maintain the tolerant environment a pregnancy requires. When those cells behave abnormally, implantation can fail even when the embryo and the uterus are both healthy.
Why Standard Testing Misses It
Conventional fertility panels measure hormones, anatomy, and genetics. None of those categories assess immune function at the site of implantation, which means an immune-related cause produces normal results across the entire standard workup.
The outcome is a diagnosis of unexplained infertility or unexplained recurrent loss. That label describes the limits of the testing performed rather than the absence of a cause.
Which Conditions Does A Reproductive Immunology Practice Treat?
Immune mechanisms contribute to several conditions that patients usually encounter through general gynecology or a fertility clinic first. A reproductive immunology practice approaches each of them through the immune lens that standard care leaves out.
Recurrent Pregnancy Loss
Two or more pregnancy losses meet the clinical definition of recurrent pregnancy loss. When chromosomal, anatomical, and hormonal testing all return normal, immune factors become one of the most important remaining explanations, and antiphospholipid syndrome is among the most significant treatable causes.
Unexplained Infertility and Multiple IVF Failures
Healthy embryos that fail to implant across technically sound transfer cycles point toward the uterine environment rather than the embryo. Immune dysfunction affecting the uterine lining is a recognized contributor to repeated implantation failure, and it accounts for a meaningful share of cases labeled unexplained.
Polycystic Ovary Syndrome
PCOS affects ovulation, hormone balance, and metabolic function together. Chronic low-grade inflammation forms part of the picture in many patients, which is why evaluation and management benefit from a practice that assesses inflammatory and metabolic markers alongside the standard hormonal panel.
Endometriosis and Adenomyosis
Both conditions involve inflammation and altered immune activity in and around the uterus. They contribute to pain, implantation difficulty, and pregnancy loss, and immune-focused evaluation adds detail that anatomical assessment alone does not provide.
Autoimmune Conditions Affecting Pregnancy
Several autoimmune presentations require specialized management through conception and pregnancy:
- Antiphospholipid syndrome: abnormal clotting that restricts placental blood flow
- Thyroid autoimmunity: anti-thyroid antibodies associated with loss and implantation failure
- Connective tissue disorders: conditions carrying documented pregnancy risk
- Autoimmune premature ovarian failure: immune-mediated loss of ovarian function
Each of these carries a direct association with reproductive failure and pregnancy complications. Managing them through a pregnancy requires monitoring and medication adjustment that continues well past conception.
Which Immune Factors Are Tested?
A reproductive immunology evaluation examines several mechanisms that standard fertility testing does not assess. Results are interpreted together, since these systems influence one another.
Natural Killer Cell Activity
Natural killer cells appear in two populations that behave very differently. Cells circulating in the bloodstream act primarily as defenders against infection, while cells within the uterine lining support implantation and vascular development.
What Is Measured
- Cytotoxicity testing: a blood test assessing how aggressively NK cells attack target cells
- Cell percentage: the proportion of circulating white blood cells these represent
- Endometrial biopsy: a sample of the uterine lining taken during the luteal phase, analyzed by flow cytometry to assess NK cells at the implantation site
Blood levels do not reliably reflect conditions inside the uterus, which is why both are assessed when the clinical picture calls for it. A normal blood result can accompany an abnormal uterine immune environment.
T-Helper Cytokine Balance
T-helper cells direct the immune response through chemical messengers called cytokines. T-Helper 1 cytokines promote inflammation, while T-Helper 2 cytokines suppress it and support tolerance.
Pregnancy requires both, in sequence. A brief inflammatory phase assists implantation, followed by a shift toward the anti-inflammatory state that protects the pregnancy. Patients with recurrent loss or repeated implantation failure frequently show an elevated T-Helper 1 to T-Helper 2 ratio, which indicates an immune environment too inflammatory to sustain a pregnancy. Flow cytometry on a blood sample measures this balance.
Antiphospholipid Antibodies
These autoantibodies promote abnormal clotting within blood vessels, which restricts blood flow to the placenta and the developing pregnancy. Associated complications include recurrent miscarriage, preeclampsia, preterm delivery, and stillbirth.
Standard and Extended Testing
Conventional testing screens for three recognized antibodies, and a positive result must be confirmed on a second occasion some weeks later. Many patients, though, present every clinical feature of the syndrome while testing negative on all three.
A reproductive immunology panel extends further, screening for additional antibodies associated with pregnancy complications that standard testing does not include. This broader approach identifies patients who would otherwise remain undiagnosed and untreated despite a clear clinical history.
Other Autoantibodies
Screening also covers antinuclear antibodies, anti-DNA, anti-SCL70, anti-histones, and anti-thyroid peroxidase, among others. Autoimmune conditions frequently affect fertility through mechanisms standard infertility evaluation does not detect, and identifying them changes both the treatment plan and the longer-term management picture.
How Does The Diagnostic Process Differ?
The workup follows a defined sequence rather than adding individual tests as previous ones return normal. Nothing is treated before results are reviewed.
Visit One: History and Testing
Medical records, previous cycles, and clinical history are reviewed in full. The complete laboratory panel is ordered at this appointment and covers four profiles together:
- Immunological: NK cell activity, T-helper cytokine ratio, autoantibody panel
- Hormonal: ovarian reserve, thyroid function, and related markers
- Hematological: clotting factors and antiphospholipid antibodies
- Metabolic: markers relevant to systemic inflammation and autoimmune activity
Ordering everything at once shortens the diagnostic phase considerably. Patients complete testing in a single round rather than returning repeatedly for one additional test at a time.
Visit Two: Results and Treatment Planning
Findings are explained in detail, along with what each result means for that patient specifically. The proposed plan is discussed before anything begins, including which abnormalities are being addressed, which medications are recommended, and how monitoring will work.
How Is Treatment Different From A Standard Fertility Protocol?
Fertility protocols are largely standardized around stimulation, retrieval, and transfer. Immune treatment works differently, because the medication depends entirely on which abnormality the testing identifies.
| Treatment | Primary Purpose | Common Indication |
| Prednisone | Immunosuppression and anti-inflammatory action | Elevated NK activity, inflammatory imbalance |
| Intravenous immunoglobulin | Immune modulation | Elevated NK cells with related abnormalities |
| Hydroxychloroquine | Autoantibody suppression | Antiphospholipid antibodies, autoimmune conditions |
| Tacrolimus | Immune pathway modulation | Profiles unresponsive to other treatment |
| Low-dose aspirin | Antiplatelet therapy | Clotting tendency |
| Enoxaparin or heparin | Anticoagulation | Antiphospholipid syndrome, clotting-related loss |
Dose and frequency vary from one patient to another, and treatment is adjusted based on repeat testing through the cycle and into early pregnancy. The purpose is restoring immune balance rather than suppressing immune function, since these pathways perform necessary work in a healthy pregnancy.
Which Patients Should Consider a Reproductive Immunology Evaluation?
Immune evaluation suits a specific group rather than everyone experiencing difficulty conceiving. Patients conceiving successfully within one or two cycles have no reason to pursue it.
The evaluation is most relevant for:
- Recurrent pregnancy loss: two or more losses without a chromosomal explanation
- Repeated implantation failure: multiple failed transfers using genetically tested embryos
- Unexplained infertility: a complete conventional workup that identified no cause
- Autoimmune history: personal or family history of autoimmune disease
- Pregnancy complications: late loss, severe early preeclampsia, or placental insufficiency
- Negative antibody testing: prior results that returned negative despite a matching clinical picture
Patients outside this profile are generally better served by continuing with their existing fertility team. A responsible specialist says so directly rather than testing everyone.
FAQs
Does reproductive immunology replace IVF treatment?
No, immune care runs alongside fertility treatment rather than replacing it. Many patients continue cycles and transfers with their existing clinic while a reproductive immunologist manages the immune evaluation and medication protocol.
Does immune treatment guarantee a successful pregnancy?
No treatment in reproductive medicine carries a guarantee. Immune evaluation identifies and addresses specific abnormalities contributing to reproductive failure, and many patients with repeated losses go on to have successful pregnancies afterward.
How long does the diagnostic phase take?
The workup typically spans two appointments, with testing completed between them. Certain antibody results require confirmation on a second occasion some weeks later, which extends the timeline for those specific findings.
Can reproductive immunology care be provided remotely?
Much of it can. Consultations and result reviews work well through telemedicine, with laboratory draws coordinated locally, though procedures such as endometrial biopsy require an in-person appointment.
Are the medications used safe during pregnancy?
These medications have established safety profiles and are prescribed at doses calibrated for reproductive use. Every prescription is individualized to test results and health history, with monitoring throughout, and specific concerns are best raised directly with the treating physician.
Final Thoughts
An unexplained diagnosis marks the boundary of what has been investigated, not the absence of a cause. For patients who have completed a full conventional workup and still have no answer, the immune system represents a category that has usually gone unexamined.
Standard fertility care asks whether conception is possible. Reproductive immunology asks whether the body’s immune system will support a healthy pregnancy. At Derbala Reproductive Immunology, every treatment plan is tailored to each patient’s specific condition. No standard protocol is applied.
Dr. Youssef Derbala is board-certified in obstetrics, gynecology, and reproductive immunology. He specializes in recurrent pregnancy loss, unexplained infertility, recurrent IVF failure, PCOS, endometriosis, and immune-related pregnancy conditions. He provides personalized care through offices in Michigan and Texas.
Get in touch with us.